TI
XENE icon

TT International’s Xenon Pharmaceuticals XENE Stock Holding History

TT International’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,352
Closed -$17K – 46
2018
Q4 		$17K Hold
1,352
– – ﹤0.01% 39
2018
Q3 		$17K Buy
+1,352
New +$15.7K ﹤0.01% 44

Other funds holding XENE

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TT International's XENE Position: Q1 2019 in Review

TT International sold out of Xenon Pharmaceuticals (XENE) in Q1 2019, closing a stake of 1,352 shares — an estimated $17K sold.

TT International first reported a position in XENE in Q3 2018 and held it in 2 quarters. The position peaked at $17K in Q4 2018. 63 funds tracked by Wall St. Rank hold XENE as of Q1 2019.

  • TT International reported no remaining Xenon Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • TT International sold 1,352 Xenon Pharmaceuticals shares in Q1 2019, an estimated $17K.
  • TT International first reported a position in Xenon Pharmaceuticals in Q3 2018 and held it in 2 quarters.
  • TT International's Xenon Pharmaceuticals position peaked at $17K in Q4 2018.
  • 63 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q1 2019.

Based on TT International's 13F filing for Q1 2019, filed 14 May 2019.